 |
Actos Bladder Cancer Lawsuit Begins
This week, the first of thousands of Actos bladder cancer lawsuits filed by former users of the diabetes drug is set to begin. Continue Reading 
March 5, 2013 | Tags: Actos, Dangerous Drugs |
|
Yet Another Study Connects Long-Term Use of Actos to Bladder Cancer
A study published this week in the Journal of the National Cancer Institute is just one of many to confirm a link between the diabetes drug Actos and bladder cancer. Continue Reading
Aug. 23, 2012 | Tags: Actos, Dangerous Drugs |
|
Another Study Identifies Actos Bladder Cancer Side Effects
Side effects linking the diabetes drug Actos to bladder cancer have been identified by yet another study. Continue Reading
July 18, 2012 | Tags: Actos, Dangerous Drugs |
|
Another Study Identifies Actos Bladder Cancer Side Effects
A new study has linked Actos to bladder cancer. Continue Reading
July 9, 2012 | Tags: Actos, Dangerous Drugs |
|
Study Clarifies Risk of Actos Bladder Cancer
Researchers from Canada have concluded that taking Actos for more than two years doubles a person’s risk of developing bladder cancer. Continue Reading
June 8, 2012 | Tags: Actos, Dangerous Drugs |
|
FDA Rejects New Diabetes Drug with Actos
Two new Takeda Pharmaceuticals diabetes drugs which contain a new treatment as well as Actos have been rejected by the FDA. Continue Reading
May 14, 2012 | Tags: Actos, Dangerous Drugs |
 |
Dr. Speaks on Actos Bladder Cancer Whistleblower Lawsuit
In a recently unsealed qui tam lawsuit, Dr. Helen Ge revealed fraud and negligence on the part of Takeda Pharmaceuticals, maker of the popular diabetes drug Actos. Continue Reading
May 7, 2012 | Tags: Actos, Dangerous Drugs, Whistleblower |
|
Canada Adds Actos Bladder Cancer Risk Warning
In Canada, health officials have issued new warnings about the risk of Actos bladder cancer associated with the drug used to treat Type II Diabetes. Continue Reading
May 3, 2012 | Tags: Actos, Dangerous Drugs |
|
Actos Judge Appointed in Multidistrict Litigation
Judge Jane L. Johnson of the Los Angeles County Superior Court has been appointed to preside over pretrial proceedings of the 22 California state court Actos lawsuits that have now been consolidated. Continue Reading
March 26, 2012 | Tags: Actos, Dangerous Drugs |
|
Whistleblower (Qui Tam) Lawsuit: Actos Heart Problems Kept from FDA
According to a recent whistleblower lawsuit, Takeda Pharmaceuticals hid evidence about the association of their drug, Actos, with congestive heart failure and the death of some Actos patients. Continue Reading
March 22, 2012 | Tags: Actos, Dangerous Drugs |
|
Leadership Roles Sought by Actos Lawyers in Federal MDL
Lawyers who wish to pursue a committee position or leadership role within the consolidated multidistrict litigation (MDL) of Actos bladder cancer lawsuits have been invited by the presiding judge to submit information on their qualifications before a hearing set for next month. Continue Reading
March 1, 2012 | Tags: Actos, Dangerous Drugs |
|
California Court Remands Actos Bladder Cancer Lawsuit
In California, a man has won the right to maintain his Actos bladder cancer lawsuit in California state court. This case could impact dozens of other Actos litigation cases. Continue Reading
Feb. 14, 2012 | Tags: Actos, Dangerous Drugs |
|
Takeda Cuts Work Force amid Actos Concerns
After recently acquiring the Swiss drug company Nycomed and amidst concerns over sales of Actos, Takeda Pharmaceuticals has stated that they plan to cut 2,800 jobs in the U.S. and in Europe. Continue Reading
Feb. 9, 2012 | Tags: Actos, Avandia, Dangerous Drugs |
|
Actos Still Valid Treatment in Spite of Bladder Cancer Risk
In Europe, health officials have deemed that Actos is a valid diabetes treatment in spite of numerous reports regarding the risk of bladder cancer for Actos users. Continue Reading
Jan. 27, 2012 | Tags: Actos, Dangerous Drugs |
|
Actos Bladder Cancer Lawsuits Coordinated in CA State Court
All Actos bladder cancer lawsuits filed in California state court will be consolidated and coordinated for pretrial proceedings. Continue Reading
Jan. 18, 2012 | Tags: Actos, Dangerous Drugs |
|
California Actos Bladder Cancer Lawsuit Moves to Federal Court
A recently filed California Actos bladder cancer lawsuit has been moved to federal court by Takeda Pharmaceuticals, the drug manufacturer. Continue Reading
Dec. 18, 2011 | Tags: Actos, Dangerous Drugs |
|
Actos Lawsuit Coordination Requested by California Lawyer
A recent Actos lawsuit case evaluation involved nine suits filed in California within 60 days. As a result, an Actos lawyer has requested that all nine of these claims be coordinated into an Actos mass tort. Continue Reading
Dec. 15, 2011 | Tags: Actos, Dangerous Drugs |
|
“Do Not Use” List: Actos Diabetes Drug
On the heels of an increasing number of Actos bladder cancer lawsuits, the non-profit consumer advocacy group Public Citizen recently reinforced their decision to add the diabetes drug Actos to their “Do Not Use” list. Continue Reading
Dec. 1, 2011 | Tags: Actos, Avandia, Dangerous Drugs |
|
Recent Actos Lawsuit: Wrongful Death Blamed on Drug
Takeda Pharmaceuticals is again under scrutiny regarding the popular diabetes drug Actos. Continue Reading
Nov. 16, 2011 | Tags: Actos, Dangerous Drugs |
 |
No Actos Recall In Europe
In Europe, drug regulators have decided not to recommend an Actos recall, despite the established link between the diabetes drug and bladder cancer. Continue Reading
Nov. 9, 2011 | Tags: Actos, Dangerous Drugs |
 |
Actos Drug Combo Launched in Japan by Takeda
On September 20, 2011, Takeda Pharmaceuticals announced the launch of Liovel, a fixed-dose combination of Nesina (alogliptin) and Actos (pioglitazone) for the treatment of type II diabetes in Japan, despite a growing number of Actos bladder cancer lawsuits being filed in the United States. Continue Reading
Nov. 3, 2011 | Tags: Actos, Dangerous Drugs |
|
Actos Bladder Cancer Litigation Consolidation: MDL Panel Set to Meet
An MDL panel of federal judges is preparing to make the decision whether to consolidate the federal Actos bladder cancer litigation before one judge for pretrial management. Continue Reading
Oct. 31, 2011 | Tags: Actos, Avandia, Dangerous Drugs |
|
Actos Bladder Cancer Class Action Lawsuit
Users of the diabetes drug Actos have filed a lawsuit against Takeda Pharmaceuticals and Eli Lily in pursuit of compensation and medical monitoring after the drug makers failed to adequately warn about the risk of bladder cancer from Actos. Continue Reading
Oct. 19, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury |
|
Takeda Actos Attorneys Support Bladder Cancer Litigation Consolidation
Takeda Pharmaceuticals lawyers have stated that they support a request to consolidate all federal Actos bladder cancer lawsuits for pretrial litigation, but they disagree about where the claims should be centralized. Continue Reading
Oct. 12, 2011 | Tags: Actos, Avandia, Dangerous Drugs |
|
Actos Bladder Cancer Lawsuits Mount
Actos bladder cancer lawsuit filings by people who have developed bladder cancer after taking the drug used to treat type 2 diabetes are increasing in number. Continue Reading
Sept. 29, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury |
 |
Lawsuit: Actos Bladder Cancer
Patients and doctors who use and prescribe the Type 2 Diabetes drug Actos (Pioglitazone) have become concerned amid recent activity by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Continue Reading
Sept. 1, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury |
 |
Actos Bladder Cancer Lawsuits Progress
The number of Actos bladder cancer lawsuits in the U.S. is expected to increase by the thousands in the near future. Continue Reading
Aug. 25, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury |
 |
FDA Approves Actos Bladder Cancer Warning
New warning language concerning the risk of Actos bladder cancer has been approved by the FDA. Continue Reading
Aug. 15, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury |
|
France Issues Actos Recall: Bladder Cancer Risks
France has issued an Actos recall as a result of concerns over a heightened risk of bladder cancer for patients who use the popular diabetes drug made by Takeda Pharmaceuticals. Continue Reading
July 20, 2011 | Tags: Actos, Dangerous Drugs |
|
Concerns About Actos Bladder Cancer Spread Across Europe
Last week, French and German officials suspended the diabetes drug Actos as a result of reports linking Actos to a higher rate of bladder cancer. Continue Reading
July 15, 2011 | Tags: Actos, Dangerous Drugs |
Free Case Evaluation
